The Environment, Social and Governance Report 2022 is the first ESG report released by SINOPHARM. The report focuses on the three themes of "Sinopharm - Navigating New High-Quality Development", "Green Sinopharm - Building a Green and Safe Home" and "Warm Sinopharm - Guarding the People's Good Life", and comprehensively demonstrates the economic, social and governance achievements of Sinopharm in 2022. SINOPHARM's comprehensive economic, social and environmental values in 2022 were comprehensively demonstrated, and SINOPHARM, as the national team and main force of the central pharmaceutical enterprises, was strongly demonstrated through the two responsibility themes of "Comprehensively Deepening Reform" and "Empowering Rural Revitalization" and the performance of the sustainable development (SDG) actions. As the national team, main force and pillar of the central pharmaceutical enterprise, Sinopharm actively serves the national strategy, improves its core competitiveness, enhances its core functions, and contributes Sinopharm's power and wisdom to build a safe, green, harmonious and beautiful society.

The report pointed out that 2022 is the opening year for the victory of the 20th CPC National Congress, the new journey of building a modern socialist country in all aspects, and the march towards the second hundred-year goal. SINOPHARM will study and implement the spirit of the 20th CPC National Congress and the spirit of important instructions from General Secretary Xi Jinping, implement the new development concept completely, accurately and comprehensively, accelerate the construction of a new development pattern, implement the "Four Pillars and Eight Pillars, One Hundred Trillions of Strengths" overall development strategy, and stride forward on the journey of accelerating the construction of a world-class enterprise. Adhering to the benefit orientation, the Company has pushed forward the work of improving quality and increasing efficiency, and its comprehensive strength and operating efficiency have reached a new level. Adhering to the principle of "people first and life first", we have strengthened the stable production and supply of medicines, and built a "lifeline" for health. Adhere to innovation-driven development, accelerate the construction of science and technology leading enterprises, and actively cultivate and grow new kinetic energy for high-quality development. Adhere to the concept of safe and low-carbon development, in-depth energy conservation, carbon reduction and synergistic efficiency, and weave a tight and solid line of defense for environmental protection and production safety. Striving for a new journey, SINOPHARM will always adhere to the Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, forge ahead, give full play to the role of scientific and technological innovation, industrial control, and safety support in the construction of a modernized industrial system and a new pattern of development, and make a new and greater contribution to the comprehensive construction of a modernized socialist country and the realization of the great rejuvenation of the Chinese nation.

SINOPHARM will take the release of the ESG report as an opportunity to further promote the in-depth integration of ESG with the company's development strategy, governance structure, and operation and management, and actively join hands with its shareholders, partners, employees and other stakeholders to carry out high-level ESG practices, help coordinate the development of the economy, the environment and the society, and contribute more power to building a world-class pharmaceutical and healthcare industrial group, accelerating the construction of the modernized industrial system of pharmaceuticals and promoting the high-quality development of the economy and society. We will contribute to building a world-class pharmaceutical and health industry group, accelerating the construction of a modernized pharmaceutical industry system, and promoting high-quality economic and social development.

https://mp.weixin.qq.com/s/HW1W0ryhXd6r4GEH4XK6RA